ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
72.00
-1.16 (-1.59%)
Oct 30, 2026, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Employees
ANI Pharmaceuticals had 970 employees as of December 31, 2025. The number of employees increased by 73 or 8.14% compared to the previous year. That makes ANI Pharmaceuticals the 15,155th largest employer in the world and 2,195th in the United States.
Employees
970
Change (1Y)
73
Growth (1Y)
8.14%
Revenue / Employee
$1,008,638
Profits / Employee
$102,677
Market Cap
1.54B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 970 | 73 | 8.14% |
| Dec 31, 2024 | 897 | 255 | 39.72% |
| Dec 31, 2023 | 642 | 42 | 7.00% |
| Dec 31, 2022 | 600 | -1 | -0.17% |
| Dec 31, 2021 | 601 | 232 | 62.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Phibro Animal Health | 2,605 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Xeris Biopharma Holdings | 435 |
ANIP News
- 7 days ago - ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET - GlobeNewsWire
- 11 days ago - ANI Pharmaceuticals launches Duloxetine Delayed-Release Capsules - TheFly
- 11 days ago - ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules - GlobeNewsWire
- 18 days ago - ANI Pharmaceuticals reports ‘positive’ results from Phase 4 Synchronicity trial - TheFly
- 4 weeks ago - ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting - GlobeNewsWire
- 5 weeks ago - ANI receives FDA approval for its ANDA for Everolimus Tablets - TheFly
- 5 weeks ago - ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension - GlobeNewsWire
- 5 weeks ago - ANI Pharmaceuticals initiated with a Perform at Oppenheimer - TheFly